New study tests bleeding drug for Kids' spine surgery
NCT ID NCT07581457
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests if tranexamic acid (TXA), a drug that reduces bleeding, is safe and effective for children aged 10-18 having surgery for idiopathic scoliosis. Participants are randomly assigned to one of two TXA dosing regimens or a placebo. The main goal is to measure total blood loss and the need for blood transfusions during and after surgery. The study is double-blind, meaning neither patients nor doctors know who gets TXA or placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCOLIOSIS IDIOPATHIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Poznan University of Medical Sciences
RECRUITINGPoznan, 62-701, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flexible spine tether could offer Motion-Saving alternative to fusion for scoliosis
- Simple grip device could help track muscle strength in scoliosis
- Virtual reality could make scoliosis exercises more effective for teens
- Video games may improve scoliosis treatment in teens
- Simple exercises may ease scoliosis in teens
- New balance system put to the test in teens with scoliosis